OJP-001

· Otsuka Medical Devices Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OJP-001, covering 2025-11-21 to 2025-11-21. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I/II Study of OJP-001 in Patients With Adult T-cell Leukemia/Lymphoma [Phase 1, Phase 2]